Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influsplit 2005/2006 immunogenicity and reactogenicity study in children aged 6 to 13 years
2005-004517-14Phase 4Completed
- Sponsor
- GSK
- Start
- Oct 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of Fluarix in influenza (2 arms), sponsored by GSK. Primary endpoints: Humoral immune response after first or only dose, Seroconversion rate and 2 more. Started Oct 2005; status: completed.
02
Drugs
Fluarix
03
Conditions
influenza
Beyond the preview
Go deeper on 2005-004517-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004517-14.